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Abstract
A 45-year old man presents with stable monomorphic ventricular tachycardia. He had previously been 
diagnosed  with  idiopathic  fascicular  ventricular  tachycardia.  Intravenous  flecainide  results  in 
termination of his tachycardia but unmasks a latent type 1 Brugada ECG pattern not seen on his resting 
ECG. We discuss his subsequent management  and the need to consider an alternative diagnosis in 
individuals  with  a  Brugada  type  ECG  pattern  who  present  with  stable  monomorphic  ventricular 
tachycardia.
            
Case  Report                                     
A 45-year old man presented with sudden onset palpitations whilst exercising. There was no associated 
hemodynamic  compromise.  Electrocardiogram (ECG) showed monomorphic ventricular  tachycardia 
(VT) with a right bundle branch block pattern and a superior axis (Figure 1A).                        
He gave a history of 3 prior episodes over the preceding 20 years and had seen an electrophysiologist  
previously. There was no history of syncope and no family history of sudden cardiac death. Resting 
ECG was within normal limits (Figure 1B) and echocardiography demonstrated a structurally normal 
heart. At that time, a diagnosis of idiopathic fascicular VT was made and after discussion the patient 
elected  not  to  undergo an  electrophysiology  study (EPS).                                      
On this occasion he was treated in the Emergency Department with IV flecainide at the instruction of 
his treating electrophysiologist.  This resulted in termination of tachycardia with restoration of sinus 
rhythm but unmasked a latent type 1 Brugada ECG pattern (Figure 1C), not seen on his resting ECG 
(Figure 1B). In view of his history of ventricular arrhythmia and a type I Brugada ECG pattern he was 
referred by the admitting team for consideration for an implantable defibrillator (ICD).
However, following discussion with the electrophysiology service, a diagnostic EPS with a view to 
ablation of his idiopathic fascicular VT was recommended. Following administration of intravenous 
isoproterenol,  monomorphic  VT  (CL  260ms)   was   easily   induced  on   multiple   occasions  with 
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programmed ventricular stimulation. This VT had an identical morphology to that seen on arrival at the 
Emergency Department. An externally irrigated ablation catheter (Cool Path Duo, St Jude Medical, St 
Paul,  MN,  USA)  was  advanced  retrogradely  to  the  left  ventricle  and  a  3  dimensional  (3D)  left 
ventricular geometry and activation map was created using Ensite Velocity  (St Jude Medical, St Paul, 
MN,  USA)  (Figure  2).                                      
Figure 1: (A) Classical left posterior fascicular VT with right bundle branch block pattern and superior axis. (B) Resting  
ECG with no ST elevation. (C)Type 1 Brugada ECG pattern with coved ST elevation and J point elevation in leads V1 and  
V2 following administration of intravenous flecainide. (D) Recordings taken at time of EPS during VT. Sweep speed of 
100mmm/sec. Displayed (from top) are 4 leads from ECG, 2 intracardiacelectrograms from quadripolar catheter at the His  
position and 2 recordings from mapping catheter (Map) in the region of the posterior fascicle.  A high frequency short 
duration  Purkinje  potential  (arrows)  is  seen  preceding  the  onset  of  the  QRS.                             
Earliest activation of the ventricle was seen at the insertion of the posterior fascicle with centrifugal 
activation of the rest of the chamber. The catheter was drawn back along the inferior septum to the 
region of the posterior fascicle until a discrete Purkinje potential could be identified preceding each 
ventricular electrogram (Figure 1D). Ablation was performed (maximum 40W) in the region of the 
posterior fascicle (Figure 2). Following ablation no polymorphic or monomorphic VT or ventricular 
fibrillation was inducible with programmed stimulation and up to 3 extra beats either in the baseline 
state  or  with  isoproterenol.                                        
Discussion
We present a case of monomorphic VT in a patient with a type 1 Brugada ECG pattern following 
injection of intravenous flecainide. This raises the possibility of either monomorphic VT as part of the 
Brugada syndrome or of a latent Brugada ECG pattern in an individual with idiopathic fascicular VT. 
The common form of idiopathic fascicular VT is characterized by a relatively narrow QRS width with 
right bundle branch block morphology and a superior axis [1]. It commonly presents in the second to 
fourth decade, is usually paroxysmal and is associated with a structurally normal heart. It is commoner 
in males and has a good prognosis. It can be induced by exercise, atrial and ventricular premature beats 
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and atrial and ventricular pacing, and can be terminated using verapamil. The tachycardia is thought to 
be due to a reentrant circuit close to the posterior fascicle of the left bundle branch. In this case the  
administration of intravenous flecainide presumably slowed a critical part of the circuit sufficiently to 
produce block thereby resulting in termination of the tachycardia and restoration of sinus rhythm. At 
EPS, high frequency Purkinje potentials are seen preceding the site of earliest ventricular activation 
during VT. Catheter ablation is the preferred treatment choice for fascicular VT with a success rate of 
greater than 90%.
Figure 2: 3D reconstruction and activation map of left the ventricle using the EnSite Velocity System. PA view is on the  
left and an extreme RAO view with inferior tilt on the right. His potentials recorded from right and left sides of septum are  
marked as L-His and R-His respectively. Sites with purkinje potentials representing the anterior and posterior fascicles of 
the left bundle branch are marked as AP and PP respectively. The PP potentials lie close to the red dots which indicate the  
site of successful ablation.  The successful ablation site is proximal to the earliest activation (displayed in white). This is 
because although the circuit is within the posterior fascicle, the activation times were calculated from near-field ventricular  
electrograms  and not  timing  of  the Purkinje  potentials.  As such,  the  earliest  ventricular  activation  is  displayed  at  the 
ventricular insertion of the Purkinje fibres. 
Brugada  syndrome  was  first  described  in  1992  and  is  characterized  by  episodes  of  syncope  or 
unexpected sudden death in patients with structurally normal hearts [2]. It classically presents with 
polymorphic  VT/VF.  Whilst  a  Brugada  ECG refers  to  the  manifestation  of  a  type  1  ST-segment 
elevation,  Brugada  syndrome  is  only  definitively  diagnosed  when  these  changes  are  observed  in 
conjunction with one or more of the following: documented VF, polymorphic VT, a family history of 
sudden cardiac death below 45 years of age, coved-type ECG changes in family members, inducibility 
of polymorphic VT with programmed electrical stimulation, syncope or nocturnal agonal respiration 
[3].
In this case although he undoubtedly has a type 1 Brugada ECG pattern he has no other features to  
indicate  he  has  Brugada  syndrome.  The  ease  of  inducibility  of  VT,  the  intra-cardiac  EGMs,  the 
activation map and the site of successful ablation all support a diagnosis of idiopathic fascicular VT as 
the  likely  cause  for  his  tachycardia.                                 
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While monomorphic VT has previously been reported in individuals with Brugada Syndrome [4] it is 
extremely rare. An ICD in this gentleman would have been inappropriate putting him a risk of potential 
defibrillation, with its associated morbidity and mortality risks, for non-life threatening arrhythmias.  
This case highlights the importance of excluding other, potentially treatable causes of idiopathic VT 
prior to ICD implantation. This is especially true in those with a Brugada type ECG pattern who are 
considered at low risk of sudden cardiac death, where appropriate ablative strategies can negate the 
need  for  a  defibrillator.                                            
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